Key result
Probands with sporadic congenital hypopituitarism had a significantly higher average number of rare, predicted-pathogenic variants in pituitary-associated genes compared to those with non-familial short stature (1.1 vs. 0.21 variants/proband, P = 0.03).
Why the study?
Congenital hypopituitarism usually occurs sporadically, and in most patients, the underlying etiology remains unknown.
Does exome sequencing reveal a monogenic etiology in children with sporadic congenital hypopituitarism compared to those with non-familial idiopathic short stature?
Case-Control (n=32)
Yes
Does exome sequencing reveal a monogenic etiology in children with sporadic congenital hypopituitarism compared to those with non-familial idiopathic short stature?
Sporadic congenital hypopituitarism has a major genetic component but is infrequently monogenic with full penetrance, suggesting a complex etiology.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for genetic causes of sporadic congenital hypopituitarism; larger validation studies required before any clinical adoption.
Purpose Congenital hypopituitarism usually occurs sporadically. In most patients, the etiology remains unknown. Methods We studied 13 children with sporadic congenital hypopituitarism. Children with non-endocrine, non-familial idiopathic short stature (NFSS) ( n = 19) served as a control group. Exome sequencing was performed in probands and both unaffected parents. A burden testing approach was used to compare the number of candidate variants in the two groups. Results First, we assessed the frequency of rare, predicted-pathogenic variants in 42 genes previously reported to be associated with pituitary gland development. The average number of variants per individual was greater in probands with congenital hypopituitarism than those with NFSS (1.1 vs. 0.21, mean variants/proband, P = 0.03). The number of probands with at least 1 variant in a pituitary-associated gene was greater in congenital hypopituitarism than in NFSS (62% vs. 21%, P = 0.03). Second, we assessed the frequency of rare, predicted-pathogenic variants in the exome (to capture undiscovered causes) that were inherited in a fashion that could explain the sporadic occurrence of the proband’s condition with a monogenic etiology ( de novo mutation, autosomal recessive, or X-linked recessive) with complete penetrance. There were fewer monogenic candidates in the probands with congenital hypopituitarism than those with NFSS (1.3 vs. 2.5 candidate variants/proband, P = 0.024). We did not find any candidate variants (0 of 13 probands) in genes previously reported to explain the phenotype in congenital hypopituitarism, unlike NFSS (8 of 19 probands, P = 0.01). Conclusion Our findings provide evidence that the etiology of sporadic congenital hypopituitarism has a major genetic component but may be infrequently monogenic with full penetrance, suggesting a more complex etiology.
No takes yet. Share an insight, caveat, or question.
Jee et al. (2021) conducted a case-control in Congenital hypopituitarism (n=32). Rare, predicted-pathogenic variants in 42 genes associated with pituitary gland development vs. Non-familial idiopathic short stature (NFSS) was evaluated on Average number of rare, predicted-pathogenic variants in 42 pituitary-associated genes per proband (p=0.03). Probands with sporadic congenital hypopituitarism had a significantly higher average number of rare, predicted-pathogenic variants in pituitary-associated genes compared to those with non-familial short stature (1.1 vs. 0.21 variants/proband, P = 0.03).
Synapse has enriched 10 related papers. Consider them for comparative context: